Trademarkia Logo

Australia

AU$
Trademark Search
TREJUVE

View On IPO.GOV.AU

TREJUVE
Cancelled: Cancelled at the request of IB

Last updated on 19 Oct 2022

Owner Info

Reata Pharmaceuticals, Inc.

2801 Gateway Drive, Suite 150

Irving TX 75063, UNITED STATES OF AMERICA

Serial Number

2118915 filed on 5 Aug 2020

Correspondent

Cynthia Johnson Walden Fish & Richardson, P.C.

PO Box 1022,

Minneapolis MN 55440-1022,

UNITED STATES OF AMERICA

TREJUVE

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of renal, cardiovascular and metabolic diseases and disorders including diabetes.

Mark Details

Serial Number

2118915

Registered On

5 Aug 2020

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

11 Mar 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
19th Oct 2022Status change to Voided
12th Jan 2021International Registration in Australia Protected correspondence sent
11th Jan 2021IP Right Registration Published
11th Jan 2021Status change to Registered/Protected
3rd Nov 2020Application Accepted correspondence sent
2th Nov 2020IP Right has been Examined
2th Nov 2020IP Right Acceptance Published
2th Nov 2020Status change to Accepted
10th Sept 2020Awaiting examination
10th Sept 2020Examination expedited